Healome Therapeutics Secures £2M Seed
Healome Therapeutics Secures £2M Seed Healome Therapeutics has secured £2 million in seed financing to develop innovative eye drop treatments for ocular surface disease, advancing their therapeutic platform. ocular surface disease treatment A New Hope for Dry Eye Sufferers Imagine waking up every morning with eyes that feel like sandpaper, struggling through the day with […]
Healome Therapeutics Secures £2M Seed Read More »










